Inventor · disambiguated record
Matthew Fuchter
Also filed as: FUCHTER MATTHEW · FUCHTER MATTHEW J · FUCHTER MATTHEW JOHN
13 granted patents·5 pending applications·26 citations·filing 2011–2023
87Inventor score
Files withCANCER RESEARCH TECH LTD4IP2IPO INNOVATIONS LTD4IMPERIAL COLLEGE INNOVATIONS LTD3IMPERIAL COLLEGE SCI TECH & MEDICINE2IMPERIAL INNOVATIONS LTD2
Top patents by PatentIndex Score
18 records- 0193US9932344B2Pyrazolo[1,5-A]pyrimidine-5,7-diamine compounds as CDK inhibitors and their therapeutic useCANCER RESEARCH TECH LTD·Filed 2015·Granted Apr 3, 2018·12 cites·30 claims
- 0288US10927119B2Pyrazolo[1,5-a]pyrimidine-5,7-diamine compounds as CDK inhibitors and their therapeutic useCANCER RESEARCH TECH LTD·Filed 2019·Granted Feb 23, 2021·3 cites·26 claims
- 0387US10414772B2Pyrazolo[1,5-A]pyrimidine-5,7-diamine compounds as CDK inhibitors and their therapeutic useCANCER RESEARCH TECH LTD·Filed 2018·Granted Sep 17, 2019·4 cites·29 claims
- 0481US11559547B2Natural killer cellsIMPERIAL COLLEGE SCI TECH & MEDICINE·Filed 2018·Granted Jan 24, 2023·2 cites·10 claims
- 0580US11945799B24-ethynylpyridine derivatives useful as GCN2 inhibitorsIP2IPO INNOVATIONS LTD·Filed 2023·Granted Apr 2, 2024·0 cites·5 claims
- 0677US9902903B2Electroluminescent compositionsIMPERIAL INNOVATIONS LTD·Filed 2013·Granted Feb 27, 2018·3 cites·12 claims
- 0776US11566226B2Natural killer cellsIMPERIAL COLLEGE SCI TECH & MEDICINE·Filed 2018·Granted Jan 31, 2023·2 cites·17 claims
- 0873US12496298B2Natural killer cellsIMPERIAL COLLEGE INNOVATIONS LTD·Filed 2023·Granted Dec 16, 2025·0 cites·19 claims
- 0969US11566029B2Pyrazolo[1,5-a]pyrimidine-5,7-diamine compounds as CDK inhibitors and their therapeutic useCANCER RESEARCH TECH LTD·Filed 2021·Granted Jan 31, 2023·0 cites·26 claims
- 1067US2025340530A1GCN2 INHIBITOR (as amended)IP2IPO INNOVATIONS LTD·Filed 2023·Application pending·0 cites
- 1164US2023271939A14-ethynylpyridine derivatives useful as gcn2 inhibitorsIP2IPO INNOVATIONS LTD·Filed 2021·Application pending·0 cites
- 1263US2025129068A14-(2-pyrazolo[3,4-b]pyridine-5-yl)ethynyl-2-pyridine derivatives useful as gcn2 inhibitorsIP2IPO INNOVATIONS LTD·Filed 2022·Application pending·0 cites
- 1356US2023002732A1Natural killer cellsIMPERIAL COLLEGE INNOVATIONS LTD·Filed 2022·Application pending·0 cites
- 1451US12497368B2Arylazo-heteroaryl compounds and their use for long-term thermal energy storageUNIV BRANDEIS·Filed 2021·Granted Dec 16, 2025·0 cites·20 claims
- 1551US2022280644A1"TRPswitch" - A STEP FUNCTION CHEMO-OPTOGENETIC LIGANDUNIV UTAH RES FOUND·Filed 2020·Application pending·0 cites
- 1644US12377119B2Natural killer cellsIMPERIAL COLLEGE INNOVATIONS LTD·Filed 2019·Granted Aug 5, 2025·0 cites·22 claims
- 1738US8507673B2Process for preparing 5,7 diaminopyrazolo [1,5-A] pyrimidine compoundsLIOTTA DENNIS C·Filed 2011·Granted Aug 13, 2013·0 cites·13 claims
- 1837US9932317B2Quinazoline compounds and their use in therapyIMPERIAL INNOVATIONS LTD·Filed 2013·Granted Apr 3, 2018·0 cites·7 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →